On Aug. 21, EVP Finance & Admin. and CFO Perier I Francis Jr sold 12,000 shares at an average price of $43. The price of the stock has increased by 51.05% since. Forest Laboratories Inc. has a market cap of $17.5 billion and its shares were traded at around $64.95. The company has a P/E ratio of 111.98 and P/S ratio of 5.39.

Forest Laboratories Inc. announced their 2013 third quarter results with revenues of $847.5 million and gross profit of $683.7 million; the net income was $69.98 million. The 2013 total revenue was $3.09 billion, a 32% decrease from the 2012 total revenue. The 2013 gross profit was $2.44 billion, a 31% decrease from the 2012 gross profit.

On Jan. 23, Director Howard Solomon sold 250,000 shares at an average price of $67.13. The price of the stock has decreased by 3.25% since. On Jan. 21, 2014, SVP-Sales Jerome Lynch sold 135,625 shares at an average price of $67.28. The price of the stock has decreased by 3.46% since. On Aug. 23, Director Lawrence S Olanoff sold 1,104 shares at an average price of $42.96. The price of the stock has increased by 51.19% since.

U.S. Bancorp (USB): Vice Chairman and CFO Andrew Cecere sold 259,355 Shares
On July 18, Vice Chairman and CFO Andrew Cecere sold 259,355 shares at an average price of $37.02. The price of the stock has increased by 0.65% since. U.S. Bancorp has a market cap of $73.31 billion and its shares were traded at around $40.14. The company has a P/E ratio of 13.50 and P/S ratio of 3.81. The dividend yield of U.S. Bancorp stocks is 2.20%; over the past 10 years, the company had an annual average earnings growth of 1.20% over the past 10 years.

U.S. Bancorp announced their 2013 third quarter results with revenues of $5.24 billion and net income of $1.47 billion. The company had a 2012 total revenue of $22.2 billion, a 3.8% increase from the 2011 total revenue. The 2012 net income was $5.6 billion, a 16% increase from the 2011 net income.

On Jan. 23, Vice Chairman P.W. Parker sold 316,696 shares at an average price of $40.56. The price of the stock has decreased by 1.04% since. On Jan. 23, Vice Chairman Pamela Joseph sold 292,604 shares at an average price of $40.63. The price of the stock has decreased by 1.21% since. On 11/12/2013, Director Victoria Buyniski Gluckman sold 158,500 shares at an average price of $37.88. The price of the stock has increased by 5.97% since.

On July 19, 2013, EVP and CFO Richard J. Johnson sold 30,000 shares at an average price of $76.58. The price of the stock has decreased by 0.27% since. PNC Financial Services Group Inc. has a market cap of $43.12 billion and its shares were traded at around $81.03. The company has a P/E ratio of 11.90 and P/S ratio of 2.69. The dividend yield of PNC Financial Services Group Inc. stocks is 2.17%; over the past 10 years, the company had an annual average earnings growth of 6.10%.

PNC Financial Services Group Inc. announced their 2013 third quarter results with revenues of $4.134 billion and net income of $1.04 billion. The company had a 2012 total revenue of $16.6 billion, a 5% increase from the 2011 total revenue. The 2012 net income was $3 billion, a 2.3% decrease from the 2011 net income.

On Jan. 22, Executive Vice President Neil F Hall sold 98,133 shares at an average price of $83.79. The price of the stock has decreased by 3.29% since. On 01/22/2014, Senior Vice Chairman Joseph C Guyaux sold 129,000 shares at an average price of $84.10. The price of the stock has decreased by 3.65% since. On 10/23/2013, President/CEO William S Demchak sold 56,584 shares at an average price of $75.44. The price of the stock has increased by 7.42% since.

On 01/02/2014, SVP, CFO Robin L Washington sold 35,600 shares at an average price of $75.03. The price of the stock has increased by 7.45% since. Gilead Sciences Inc. has a market cap of $123.62 billion and its shares were traded at around $80.62. The company has a P/E ratio of 44.10 and P/S ratio of 12.64. Over the past 5 years, Gilead Sciences Inc had an annual average earnings growth of 14.80%.

Gilead Sciences Inc. announced their 2013 third quarter results with revenues of $2.78 billion and gross profit of $2.1 billion; the net income was $788.6 million. The 2012 total revenue for Gilead Sciences Inc was $9.7 billion, a 15.7% increase from the 2011 total revenue. The 2012 gross profit was $7.23 billion, a 15.5% increase from the 2011 gross profit.

On Jan. 21, EVP, Corp & Med Affairs Gregg H Alton sold 120,000 shares at an average price of $80. The price of the stock has increased by 0.78% since. On Jan. 14, EVP, R&D and CSO Norbert W Bischofberger sold 90,000 shares at an average price of $74.23. The price of the stock has increased by 8.61% since. On Jan. 2, Chairman and CEO John Martin sold 140,625 shares at an average price of $75.02. The price of the stock has increased by 7.46% since.

Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.
Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.